NEW YORK (GenomeWeb News) – Molecular diagnostics company Prodesse said today that the US Food and Drug Administration has authorized two changes to the packaging on the company’s influenza assay.
 
The FDA, which cleared the company’s ProFlu+ at the beginning of 2008, has accepted using the bioMérieux NucliSENS easyMAG automated nucleic acid extraction system with the ProFlu+ test, the company said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.